- Home
- LRMR vs WENN Comparison
LRMR vs WENN Comparison
Compare LRMR & WENN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.47
Company Overview
Basic Information| Metric | LRMR | WENN |
|---|---|---|
| Founded | N/A | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.8M | 381.2M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | LRMR | WENN |
|---|---|---|
| Price | $3.47 | $10.28 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | ★ 2.0M | 20.7K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,816.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.26 | $9.67 |
| 52 Week High | $6.42 | $10.38 |
Technical Indicators
Market Signals| Indicator | LRMR | WENN |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 60.13 |
| Support Level | $3.10 | $10.15 |
| Resistance Level | $3.74 | $10.37 |
| Average True Range (ATR) | 0.20 | 0.01 |
| MACD | 0.06 | -0.00 |
| Stochastic Oscillator | 81.29 | 33.33 |
Price Performance
Historical Comparison LRMR
WENN
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About WENN Wen Acquisition Corp Class A Ordinary Shares
Wen Acquisition Corp is a blank check company.